UroGen Pharma Says FDA Approves Plan For Rolling NDA Submission For UGN-102 From January 2024

RTTNews | 1085 days ago
UroGen Pharma Says FDA Approves Plan For Rolling NDA Submission For UGN-102 From January 2024

(RTTNews) - Biotech company UroGen Pharma Ltd. (URGN) announced Tuesday that it has reached agreement with the U.S. Food and Drug Administration (FDA) on plans for submission of a New Drug Application (NDA) for UGN-102 (mitomycin) for intravesical solution.

The FDA indicated that the current clinical development plan for UGN-102, which includes evaluation of duration of complete response (CR) at 12 months from the pivotal ENVISION trial, will support submission of an NDA for the treatment of low-grade intermediate-risk non-muscle invasive bladder cancer (LG-IR-NMIBC).

The FDA also agreed that the UGN-102 NDA can utilize a rolling review, allowing for early submission of the Chemistry, Manufacturing and Controls (CMC) sections of the NDA, which is planned for January 2024.

If approved, UGN-102 has the potential to introduce a new non-surgical treatment paradigm for LG-IR-NMIBC, a subset of bladder cancer patients characterized by high recurrence rates and the need for multiple surgeries.

The UGN-102 clinical development plan centers around the Phase 3 ENVISION pivotal trial and is supported by robust clinical data from the ATLAS Phase 3 and OPTIMA Phase 2b trials.

read more
UroGen Pharma Files Patent Infringement Lawsuit Against Teva Pharma

UroGen Pharma Files Patent Infringement Lawsuit Against Teva Pharma

Biotech company UroGen Pharma Ltd. (URGN) announced Wednesday that it has filed a lawsuit in the U.S. District Court for the District of Delaware against Teva Pharmaceuticals, Inc., Teva Pharmaceuticals USA, Inc., and Teva Pharmaceutical Industries, Ltd. (TEVA), alleging infringement of U.S. Patent Numbers 9,040,074 and 9,950,069.
RTTNews | 902 days ago
U.S. Stocks Likely To Open On Cautious Note

U.S. Stocks Likely To Open On Cautious Note

U.S. stocks look headed for a cautious start on Tuesday, as investors await some crucial geopolitical news for directional clues. Easing concerns about inflation following another sharp drop in oil prices could aid sentiment.
RTTNews | 41 minutes ago
UK Borrowing Overshoots Estimate

UK Borrowing Overshoots Estimate

The UK government borrowing exceeded the government estimate in August as spending rose more than income, partly due to the impacts of inflation, data from the Office for National Statistics said Tuesday. Public sector net borrowing increased GBP 2.9 billion from the previous year to GBP 18.3 billion in August.
RTTNews | 1h 6min ago
AutoZone Q4 Profit, Comps Rise; Sees Sales Growth In FY27

AutoZone Q4 Profit, Comps Rise; Sees Sales Growth In FY27

AutoZone, Inc., an automotive replacement parts retailer, reported Tuesday higher profit in its fourth quarter with growth in net sales and same store sales. Looking ahead, the company said it is well positioned for sales growth in fiscal 2027. In the pre-market activity on the NYSE, the shares were gaining around 0.53 percent.
RTTNews | 1h 20min ago
U.K. Stocks Turning In Mixed Performance; FTSE 100 Up Marginally

U.K. Stocks Turning In Mixed Performance; FTSE 100 Up Marginally

U.K.'s equity benchmark FTSE 100 was up in positive territory a little past noon on Tuesday with stocks turning in a mixed performance as investors assessed the Middle East situation and looked ahead to U.S. President Donald Trump's speech at the U.N. General Assembly later in the day.
RTTNews | 1h 51min ago
Indian Shares End Slightly Lower In Volatile Trade

Indian Shares End Slightly Lower In Volatile Trade

Indian shares ended slightly lower after a choppy session on Tuesday as oil prices fluctuated after declining for four consecutive sessions, and hawkish signals from Federal Reserve policymakers reinforced expectations of further interest-rate hikes by the U.S. central bank this year.
RTTNews | 2h 47min ago